{"id":"https://openalex.org/W2146956830","doi":"https://doi.org/10.1136/gut.2005.083113","title":"Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy","display_name":"Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy","publication_year":2006,"publication_date":"2006-05-18","ids":{"openalex":"https://openalex.org/W2146956830","doi":"https://doi.org/10.1136/gut.2005.083113","mag":"2146956830","pmid":"https://pubmed.ncbi.nlm.nih.gov/16709661","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1860092"},"language":"en","primary_location":{"id":"doi:10.1136/gut.2005.083113","doi":"https://doi.org/10.1136/gut.2005.083113","is_oa":true,"landing_page_url":"https://doi.org/10.1136/gut.2005.083113","pdf_url":"https://gut.bmj.com/content/gutjnl/55/11/1631.full.pdf","source":{"id":"https://openalex.org/S3251770","display_name":"Gut","issn_l":"0017-5749","issn":["0017-5749","1468-3288"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gut","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://gut.bmj.com/content/gutjnl/55/11/1631.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052025506","display_name":"Morris Sherman","orcid":"https://orcid.org/0000-0003-4983-3049","observed_orcids":["https://orcid.org/0000-0003-4983-3049"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I2801845744","display_name":"Toronto General Hospital","ror":"https://ror.org/026pg9j08","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2801845744"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"M Sherman","raw_affiliation_strings":["University Health Network, Toronto General Hospital, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Health Network, Toronto General Hospital, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2801845744"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067141465","display_name":"Eric M. Yoshida","orcid":"https://orcid.org/0000-0003-2910-7461","observed_orcids":["https://orcid.org/0000-0003-2910-7461"]},"institutions":[{"id":"https://openalex.org/I2799475292","display_name":"Vancouver Hospital and Health Sciences Centre","ror":"https://ror.org/05p83my93","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I141074466","https://openalex.org/I2799475292"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"E M Yoshida","raw_affiliation_strings":["Vancouver Hospital Health Sciences Centre, Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vancouver Hospital Health Sciences Centre, Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I2799475292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000299287","display_name":"Marc Desch\u00eanes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088756","display_name":"Royal Victoria Hospital","ror":"https://ror.org/00arwy491","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801766832","https://openalex.org/I2801902503","https://openalex.org/I4210088756","https://openalex.org/I4210139015","https://openalex.org/I4405279980"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"M Deschenes","raw_affiliation_strings":["Royal Victoria Hospital, Montreal, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Victoria Hospital, Montreal, Quebec, Canada","institution_ids":["https://openalex.org/I4210088756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079171066","display_name":"Mel Krajden","orcid":"https://orcid.org/0000-0002-3477-8748","observed_orcids":["https://orcid.org/0000-0002-3477-8748"]},"institutions":[{"id":"https://openalex.org/I2802940977","display_name":"BC Centre for Disease Control","ror":"https://ror.org/05jyzx602","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1308729876","https://openalex.org/I156965999","https://openalex.org/I2802940977"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"M Krajden","raw_affiliation_strings":["British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I2802940977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071465537","display_name":"Vincent G. Bain","orcid":"https://orcid.org/0000-0002-9930-6696","observed_orcids":["https://orcid.org/0000-0002-9930-6696"]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"V G Bain","raw_affiliation_strings":["University of Alberta, Edmonton, Alberta, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alberta, Edmonton, Alberta, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079973794","display_name":"Kevork Minas Peltekian","orcid":"https://orcid.org/0000-0002-9560-5576","observed_orcids":["https://orcid.org/0000-0002-9560-5576"]},"institutions":[{"id":"https://openalex.org/I2800264117","display_name":"Queen Elizabeth II Health Sciences Centre","ror":"https://ror.org/025qrzc85","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2800264117","https://openalex.org/I2802394193"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"K Peltekian","raw_affiliation_strings":["QEII-Health Sciences Centre, Hepatology Services, Halifax, Nova Scotia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"QEII-Health Sciences Centre, Hepatology Services, Halifax, Nova Scotia, Canada","institution_ids":["https://openalex.org/I2800264117"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069226531","display_name":"Frank Anderson","orcid":"https://orcid.org/0000-0002-9055-8037","observed_orcids":["https://orcid.org/0000-0002-9055-8037"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Anderson","raw_affiliation_strings":["The Liver and Intestinal Research Centre, Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Liver and Intestinal Research Centre, Vancouver, British Columbia, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061949081","display_name":"Kelly Kaita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I46247651","display_name":"University of Manitoba","ror":"https://ror.org/02gfys938","country_code":"CA","type":"education","lineage":["https://openalex.org/I46247651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"K Kaita","raw_affiliation_strings":["Viral Hepatitis Investigative Unit, University of Manitoba, Winninpeg, Manitoba, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Viral Hepatitis Investigative Unit, University of Manitoba, Winninpeg, Manitoba, Canada","institution_ids":["https://openalex.org/I46247651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106788436","display_name":"Susan Simonyi","orcid":"https://orcid.org/0000-0002-1236-4026","observed_orcids":["https://orcid.org/0000-0002-1236-4026"]},"institutions":[{"id":"https://openalex.org/I4210089084","display_name":"Roche (Canada)","ror":"https://ror.org/006hrz834","country_code":"CA","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210089084"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"S Simonyi","raw_affiliation_strings":["Roche, Mississauga, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche, Mississauga, Ontario, Canada","institution_ids":["https://openalex.org/I4210089084"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044718702","display_name":"Robert F Balshaw","orcid":"https://orcid.org/0000-0002-2455-8792","observed_orcids":["https://orcid.org/0000-0002-2455-8792"]},"institutions":[{"id":"https://openalex.org/I4392738247","display_name":"Syreon Corporation (Canada)","ror":"https://ror.org/00j39jc12","country_code":"CA","type":"company","lineage":["https://openalex.org/I4392738247"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"R Balshaw","raw_affiliation_strings":["Syreon Corporation, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Syreon Corporation, British Columbia, Canada","institution_ids":["https://openalex.org/I4392738247"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042678528","display_name":"Samuel S. Lee","orcid":"https://orcid.org/0000-0003-4431-272X","observed_orcids":["https://orcid.org/0000-0003-4431-272X"]},"institutions":[{"id":"https://openalex.org/I168635309","display_name":"University of Calgary","ror":"https://ror.org/03yjb2x39","country_code":"CA","type":"education","lineage":["https://openalex.org/I168635309"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"S S Lee","raw_affiliation_strings":["University of Calgary, Calgary, Alberta, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Calgary, Calgary, Alberta, Canada","institution_ids":["https://openalex.org/I168635309"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5052025506"],"corresponding_institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2801845744"],"apc_list":null,"apc_paid":null,"fwci":10.1509,"has_fulltext":true,"cited_by_count":88,"citation_normalized_percentile":{"value":0.98312597,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"55","issue":"11","first_page":"1631","last_page":"1638"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11495","display_name":"Animal Virus Infections Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10276","display_name":"Helicobacter pylori-related gastroenterology studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.8960000276565552},{"id":"https://openalex.org/keywords/peginterferon-alfa-2a","display_name":"peginterferon alfa-2a","score":0.9769999980926514},{"id":"https://openalex.org/keywords/ribavirin","display_name":"ribavirin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/interferon-non-responders","display_name":"interferon non-responders","score":0.7599999904632568},{"id":"https://openalex.org/keywords/sustained-virologic-response","display_name":"sustained virological response","score":0.9779999852180481},{"id":"https://openalex.org/keywords/hcv-genotype-1","display_name":"HCV genotype 1","score":0.9269999861717224},{"id":"https://openalex.org/keywords/hcv-genotype-2-3","display_name":"HCV genotype 2/3","score":0.9599999785423279},{"id":"https://openalex.org/keywords/retreatment","display_name":"retreatment","score":0.527999997138977}],"concepts":[{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.917773425579071},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8897923231124878},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7031152248382568},{"id":"https://openalex.org/C2776235749","wikidata":"https://www.wikidata.org/wiki/Q420056","display_name":"Peginterferon alfa-2a","level":5,"score":0.6958933472633362},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6193138957023621},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4843091070652008},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.48098576068878174},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.4701661765575409},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.4556137025356293},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.43577373027801514},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.4252474009990692},{"id":"https://openalex.org/C3020491458","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Chronic hepatitis","level":3,"score":0.42454737424850464},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.42039763927459717},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.324398010969162},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.22870531678199768},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.1898469626903534},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010352","descriptor_name":"Patient Dropouts","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017211","descriptor_name":"Treatment Failure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1136/gut.2005.083113","doi":"https://doi.org/10.1136/gut.2005.083113","is_oa":true,"landing_page_url":"https://doi.org/10.1136/gut.2005.083113","pdf_url":"https://gut.bmj.com/content/gutjnl/55/11/1631.full.pdf","source":{"id":"https://openalex.org/S3251770","display_name":"Gut","issn_l":"0017-5749","issn":["0017-5749","1468-3288"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gut","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1860092","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1860092","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gut","raw_type":"Text"},{"id":"pmid:16709661","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16709661","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gut","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1136/gut.2005.083113","doi":"https://doi.org/10.1136/gut.2005.083113","is_oa":true,"landing_page_url":"https://doi.org/10.1136/gut.2005.083113","pdf_url":"https://gut.bmj.com/content/gutjnl/55/11/1631.full.pdf","source":{"id":"https://openalex.org/S3251770","display_name":"Gut","issn_l":"0017-5749","issn":["0017-5749","1468-3288"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gut","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320310452","display_name":"Hamilton Health Sciences","ror":"https://ror.org/02dqdxm48"},{"id":"https://openalex.org/F4320310898","display_name":"London Health Sciences Centre","ror":"https://ror.org/037tz0e16"},{"id":"https://openalex.org/F4320322842","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2146956830.pdf","grobid_xml":"https://content.openalex.org/works/W2146956830.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W47800385","https://openalex.org/W1978992694","https://openalex.org/W1992239172","https://openalex.org/W1993359553","https://openalex.org/W1996434966","https://openalex.org/W2027545702","https://openalex.org/W2038400084","https://openalex.org/W2049143320","https://openalex.org/W2052545199","https://openalex.org/W2059196197","https://openalex.org/W2060690132","https://openalex.org/W2074890947","https://openalex.org/W2085261733","https://openalex.org/W2112876622","https://openalex.org/W2117617441","https://openalex.org/W2121649395","https://openalex.org/W2127685726","https://openalex.org/W2165715544","https://openalex.org/W2317554121","https://openalex.org/W2341829866","https://openalex.org/W2408081177","https://openalex.org/W2426931570","https://openalex.org/W2466165747","https://openalex.org/W2506210560","https://openalex.org/W2564042923","https://openalex.org/W2781301350","https://openalex.org/W3195153543","https://openalex.org/W4229999340","https://openalex.org/W4247506833","https://openalex.org/W4251925572","https://openalex.org/W4254565755","https://openalex.org/W6979014210","https://openalex.org/W7070292702"],"related_works":["https://openalex.org/W1802345175","https://openalex.org/W2085261733","https://openalex.org/W2098036743","https://openalex.org/W1978992694","https://openalex.org/W2086667773","https://openalex.org/W2110405210","https://openalex.org/W2134194979","https://openalex.org/W2046440272","https://openalex.org/W2520579005","https://openalex.org/W2071277949"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,102,121,142],"management":[2],"of":[3,33,110,139,153,244],"patients":[4,115,155,165],"with":[5,53,83,116,251],"chronic":[6],"hepatitis":[7,56],"C":[8,57],"who":[9,61],"have":[10],"relapsed":[11,67],"or":[12,65,72,95],"failed":[13],"to":[14,16,148,240],"respond":[15],"interferon":[17,71],"based":[18],"therapies":[19],"is":[20,238],"an":[21],"important":[22],"issue":[23],"facing":[24],"hepatologists.":[25],"AIMS:":[26],"We":[27],"evaluated":[28],"the":[29,99,107],"efficacy":[30],"and":[31,171,180,202,221,247],"safety":[32],"peginterferon":[34,84,252],"alfa-2a":[35,85,253],"(40KD)":[36,86,254],"plus":[37,89,255],"ribavirin":[38,90,111],"in":[39,218,224,230],"this":[40],"population":[41],"by":[42,146,211,249],"conducting":[43],"a":[44,231,242],"multicentre":[45],"open":[46],"label":[47],"study.":[48],"PATIENTS:":[49],"Data":[50],"from":[51],"adults":[52],"detectable":[54],"serum":[55],"virus":[58],"(HCV)":[59],"RNA":[60,133],"had":[62,66,187],"not":[63],"responded":[64],"after":[68,136],"previous":[69,245],"conventional":[70,73],"interferon/ribavirin":[74],"combination":[75],"therapy":[76],"were":[77,81,160,166,182,197,209,215],"analysed.":[78],"METHODS:":[79],"Patients":[80],"retreated":[82],"180":[87],"microg/week":[88],"800":[91],"mg/day":[92],"for":[93,114,168,173,200,205],"24":[94,137,169],"48":[96,174],"weeks":[97,138,170],"at":[98],"investigators'":[100],"discretion.":[101],"study":[103],"was":[104,119,124,144],"conceived":[105],"before":[106],"optimal":[108],"dose":[109],"(1000/1200":[112],"mg/day)":[113],"genotype":[117,188,219,225],"1":[118,189,220],"known.":[120],"primary":[122],"endpoint":[123],"sustained":[125],"virological":[126],"response":[127],"(SVR),":[128],"defined":[129],"as":[130],"undetectable":[131],"HCV":[132],"(<50":[134],"IU/ml)":[135],"follow":[140],"up.":[141],"analysis":[143],"conducted":[145],"intention":[147],"treat.":[149],"RESULTS:":[150],"A":[151],"total":[152],"312":[154],"(212":[156],"non-responders,":[157],"100":[158],"relapsers)":[159],"included.":[161],"Of":[162],"these,":[163],"28":[164],"treated":[167],"284":[172],"weeks.":[175],"Baseline":[176],"characteristics":[177],"between":[178],"non-responders":[179,186,201,246],"relapsers":[181,248],"similar":[183],"although":[184],"more":[185],"infection":[190],"(87%":[191],"v":[192],"69%).":[193],"Overall":[194],"SVR":[195,213],"rates":[196,214],"23%":[198],"(48/212)":[199],"41%":[203],"(41/100)":[204],"relapsers.":[206],"When":[207],"data":[208],"analysed":[210],"genotype,":[212],"24%":[216],"(61/253)":[217],"47%":[222],"(28/59)":[223],"2/3.":[226],"CONCLUSIONS:":[227],"These":[228],"results":[229],"large":[232],"patient":[233],"cohort":[234],"demonstrate":[235],"that":[236],"it":[237],"possible":[239],"cure":[241],"proportion":[243],"retreating":[250],"ribavirin.":[256]},"counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":8}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}